![Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/958f3e63-5eff-4a4d-8f92-96eec097953c/gr1.jpg)
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine
![An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy](https://images.squarespace-cdn.com/content/v1/58d944d2ebbd1aac620cfead/1595348701852-HZ2V1OZPBMQCSVC8ULU6/Chart-4.jpg)
An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy
![Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms](https://www.mdpi.com/diagnostics/diagnostics-13-02338/article_deploy/html/images/diagnostics-13-02338-g001.png)
Diagnostics | Free Full-Text | Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
![Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement | Allergologia et Immunopathologia Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement | Allergologia et Immunopathologia](https://static.elsevier.es/multimedia/03010546/0000004800000006/v1_202011271043/S0301054620301154/v1_202011271043/en/main.assets/xTab2439252.png)
Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement | Allergologia et Immunopathologia
![Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/asset/4dd43524-dcf7-466a-a39e-5413f3d8ea78/gr1.gif)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
![Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1878747923007109-gr2.jpg)
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy - ScienceDirect
![Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms | Clinical Reviews in Allergy & Immunology Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms | Clinical Reviews in Allergy & Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12016-015-8499-2/MediaObjects/12016_2015_8499_Fig1_HTML.gif)